Related Experiment Video
Updated: Oct 7, 2025

Acute Kidney Injury Model Induced by Cisplatin in Adult Zebrafish
Published on: May 15, 2021
Acute liver damage and interaction of cisplatin with silver nanoparticles depend on particle size
A Yukina1, S Yoshimi1, I Isao1
1Faculty of Pharmaceutical Sciences, Teikyo Heisei University, Nakano-ku, Tokyo, Japan.
Abstract:
Nanomaterials are innovative materials that have novel properties that differ from those of macroscale materials in terms of response to stimuli such as heat, light, and voltage. However, the potential unknown effects of nanomaterials on living organisms have raised concerns. There are few reports describing the effects of silver nanoparticles on living organisms and the effects of nanoparticle interactions with chemical substances such as pharmaceuticals. Previously, we investigated the effects of silver nanoparticles on living organisms and their interactions with drugs. In that study, silver nanoparticles with a particle size of 10 nm induced acute liver injury, and silver nanoparticles with a particle size of 10, 50, or 200 nm interacted with drugs when administered to mice via the tail vein. Therefore, to investigate the relationship between the particle size of silver nanoparticles and degree of injury, we examined silver nanoparticles of 5, 10, 20, 30, 40, and 50 nm and the extent of acute liver injury and liver injury due to interactions with drugs. We found that silver nanoparticles ≤30 nm in size induced acute liver injury. Silver nanoparticles with a 5-nm particle size induced the most severe liver injury.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

